久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Serving in the name of progress

By Zhong Nan | China Daily | Updated: 2017-09-08 07:29

Serving in the name of progress

Joaquin Duato, executive vice-president and worldwide chairman of pharmaceuticals at Johnson & Johnson. [Photo provided to China Daily]

A senior executive at Johnson & Johnson talks about the group's strategy in China and the rest of the world

Joaquin Duato had dreams of playing tennis for Spain as a child.

At 55, he is now the executive vice-president and worldwide chairman of pharmaceuticals at blue chip brand Johnson& Johnson.

"I'm an avid tennis player and as a child I used to dream of one day representing Spain," he said during a visit to Beijing.

Instead he has represented the global healthcare giant for the past 28 years and helped shape the multinational's strategy in China and across the world.

"The healthcare and pharmaceutical industries have developed notably in China during the past three decades," Duato said. "Pharmaceutical companies are getting medicines to patients faster than they were before."

Moves by the China Food and Drug Administration to streamline the approval of new medicines have opened up the industry along with updating the National Reimbursement Drug List.

Last month, the Johnson & Johnson subsidiary, Xi'an Janssen Pharmaceutical Ltd, was granted approval from the CFDA for its Imbruvica capsules, which are used to treat adult patients with chronic lymphocytic leukemia and mantle cell lymphoma.

"These factors have improved the situation in China for innovation-based pharmaceutical companies," Duato added.

With more than 125,000 staff in nearly 60 countries and regions, Johnson & Johnson sells its products, such as consumer and healthcare, pharmaceuticals and medical devices, in about 200 nations and regions.

Naturally, China has become "vitally" important to the United States-based group.

In an interview with China Daily, Duato talked about the company's vision, its strategy in China, and his love of tennis and giant pandas.

What are Johnson & Johnson's plans in China during the next five years?

China is vitally important to us globally and we remain committed to investing in China, and making a significant contribution to the country's economic growth.

Since establishing operations here in 1985, we have expanded our presence significantly and today employ more than 2,500 people in our Beijing headquarters, our state-of-the-art manufacturing site in Xi'an, and our research and development operations. These include the groundbreaking R&D center in Shanghai and the Johnson & Johnson Innovation Center.

Following an investment of $290 million, our new supply chain hub for innovation in Asia is scheduled to open in Xi'an (in Shaanxi province) in 2019. The objective is to serve the rapidly expanding needs of China and other markets in the region. The plant is expected to set a new standard in pharmaceutical manufacturing here.

At full capacity, the plant is expected to produce 400 million tablets, capsules, creams, suppositories and powders a year.

What are your priorities in the country?

Globally, and in China, our strategy is to focus on discovering and developing transformational medical innovations for patients in six high priority disease areas, which address major unmet (unfulfilled) treatment needs.

These include oncology, immunology, neuroscience, infectious diseases, cardiovascular and pulmonary hypertension.

We will (also) continue to support China's aspiration to become a leading global pharmaceutical innovator through forward-looking investments. This will enable the discovery of game-changing therapies which address unmet medical needs.

What business opportunities will emerge through the Belt and Road Initiative?

Xi'an Janssen was, and will continue to be, a forerunner in establishing joint ventures with local partners in China. We established our operations in Shaanxi province in 1985, a critical area of the Belt and Road Initiative.

We also attribute these joint-venture partnerships and our continued investment in Xi'an as critical factors to our success in China. We will continue this model (in the future).

What is your biggest achievement here?

I am proud of guiding the business toward a greater focus on transformational medical innovations for patients.

Zytiga, a new kind of treatment for men with (a type of) prostate cancer, is a great example of cutting-edge science and true medical innovation that significantly prolongs lives.

How will you compete with competitors across the world and in China?

In 2011, we made the decision to focus our business on identifying and bringing transformational medical innovation. We are an innovation-based company which globally spends 50 percent more in research and development than in sales and marketing.

With a growing core business of medicines and a strong lineup of innovative products expected to launch or file during the next five years, we are leading the industry in advancing the health of patients around the world.

With our proven global commercial capabilities, we are well-positioned to continue delivering strong, long-term, sustainable growth.

How does digital technology affect your business?

Digital technology is important in discovery and development because we use information technology to screen targets and to model our clinical trial designs.

It is critical in manufacturing as we use machine learning and artificial intelligence, or AI, to identify areas in which we can eliminate waste and establish better quality control measures.

We now have access to vast amounts of data about how our medicines are used by physicians and patients once they are on the market. So this helps us better understand the risk-benefit ratio.

What makes an effective leader of a major multinational company?

I am proud to have worked at Johnson & Johnson for more than 28 years. I have had a varied career in different sectors of the healthcare industry, and in different countries and regions around the world. This has helped me continue to evolve and adapt my leadership style.

For the first half of my career, I was based in Europe and I was successful by using a direct, straight forward leadership style. But after moving to the United States I had to re-evaluate my style and learn to navigate cultural differences.

I would say my key leadership approach is adaptability-being able to draw upon what best suits the situation and the team I am leading.

How has your style changed over time?

Different business challenges need different leadership styles. When I became the head of our North American operation, I had to work quickly and alone to guide the business through a challenging turnaround.

But once it had stabilized, I had to open up to a more inclusive and consultative leadership style as we developed a long-term strategy for growth.

How do you handle setbacks?

I view setbacks as opportunities to grow, both as an individual and as a business. The challenges and hardships our group faced during the 2007 recession can almost be seen as a necessary step in achieving the remarkable success we have today.

The setbacks we faced forced us to make our organization a leaner and more focused operation. Our extremely successful model of embracing innovation was born.

So now, whenever I am faced with a setback, I always look for an opportunity that might arise.

What are your hobbies?

My role involves a lot of travel, so whenever I am at home my first priority is spending time with my family. I love being with my wife, son and daughter.

This summer, I have spent a number of days traveling with my family to visit potential colleges that my daughter might attend next year.

I am also an avid tennis player and as a child I used to dream of one day representing Spain.

How do you spend your free time in China?

Usually, I am focused on meetings with customers and government officials. But I understand that through our collaboration with Shaanxi Rare Wild Animals Rescue and Research Center, which aims to further protect the giant panda in China, we had the honor of naming a baby panda "Johnson& Johnson". If I have free time, I am hoping to visit him.

CV

Age: 55

Nationality: Spanish and American

Career:

2017 onwards: Chairman of the Board, PhRMA

2011 onwards: Worldwide Chairman, Pharmaceuticals, Johnson& Johnson

2009-11: Company Group Chairman, Americas, The Janssen Pharmaceutical Companies of Johnson& Johnson

2007-09: Company Group Chairman, Diagnostics, Johnson & Johnson

2005-07: President, Ortho Biotech Products LP, Johnson& Johnson

Education: Undergraduate degree in Economics and Business

MBA from ESADE, Barcelona

Masters of International Management from Thunderbird, Phoenix, US.

Family: Married with a son and a daughter

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    88av.com| 国产69精品久久久久久久| 欧美国产日韩激情| 538在线视频观看| 久久艹国产精品| 57pao国产成永久免费视频| 久久久久99精品成人片| 色天使在线观看| 欧美三级一级片| 91视频成人免费| 亚洲综合日韩欧美| 国产中文字幕免费观看| 波多野结衣 作品| 亚洲另类第一页| 久久久久久久久久久免费视频| 欧美 国产 精品| 在线播放av中文字幕| 人妻丰满熟妇av无码区app| 日韩视频免费播放| 穿情趣内衣被c到高潮视频| 无限资源日本好片| 国产男女无遮挡| 久久久久久免费看| 成年人视频大全| 国产日本欧美在线| 国内外成人免费在线视频| 亚洲中文字幕无码不卡电影| 精品一区二区三区无码视频| 午夜久久久久久久久久久| 狠狠干狠狠操视频| 美女网站视频黄色| 黑人粗进入欧美aaaaa| 欧美 日韩 国产一区| 丝袜人妻一区二区三区| 日本高清视频免费在线观看| 国产精品h视频| 国产又大又黄又粗又爽| 毛片毛片毛片毛片毛片毛片毛片毛片毛片 | 霍思燕三级露全乳照| 国产免费一区二区三区四在线播放| 日本在线观看免费视频| www.国产区| 精品国产成人av在线免| 欧美日韩在线视频一区二区三区| 欧美,日韩,国产在线| 午夜免费福利小电影| 成人免费播放器| 黄色av网址在线播放| 午夜免费福利小电影| 欧美精品一区免费| 国产二区视频在线播放| 北条麻妃在线观看| 日本女优爱爱视频| 日韩一级理论片| 五月天开心婷婷| 青娱乐精品在线| 91免费视频黄| 亚洲精品久久久久久久蜜桃臀| 日本天堂免费a| 亚洲国产精品无码观看久久| 免费观看国产精品视频| 18禁免费无码无遮挡不卡网站| 欧美三级午夜理伦三级| 最近中文字幕一区二区| 精品综合久久久久| 可以免费看的黄色网址| 欧美国产日韩激情| 欧美精品一区二区三区免费播放| 欧洲av无码放荡人妇网站| av免费网站观看| 久久久久久久久久久久久久久国产| 999久久久精品视频| 天天在线免费视频| 国产人妻777人伦精品hd| 国内外成人激情视频| 香蕉视频网站入口| 国产精品h视频| 91丨porny丨探花| www.色就是色| 国产奶头好大揉着好爽视频| 欧美一级视频免费看| 国产精品天天av精麻传媒| 午夜影院免费观看视频| 欧美中文字幕在线观看视频| 欧美黄网站在线观看| 日日干夜夜操s8| 久久综合亚洲精品| 日本va中文字幕| 超碰中文字幕在线观看| 男人和女人啪啪网站| 精品日韩久久久| 欧美乱做爰xxxⅹ久久久| 超碰97人人射妻| 久久久久久久久久毛片| 国产精品专区在线| 在线看免费毛片| 精品少妇一区二区三区在线| 国产一二三区av| 女人帮男人橹视频播放| 手机在线看福利| 久久99久久99精品| 九九热精品国产| 亚洲熟妇无码另类久久久| 一区二区三区四区毛片| 国产淫片免费看| 色乱码一区二区三区熟女| 看av免费毛片手机播放| 成人手机视频在线| 91av在线免费播放| 国产精品videossex国产高清| 在线观看免费成人av| 草b视频在线观看| 三级av免费看| 国产嫩草在线观看| av免费看网址| 日本特黄在线观看| 欧美性猛交xxx乱久交| 男人添女荫道口女人有什么感觉| 高潮一区二区三区| 丰满人妻中伦妇伦精品app| japanese在线播放| 成年网站免费在线观看| 国产视频九色蝌蚪| av日韩在线看| 成人性生交视频免费观看| 丰满少妇在线观看| 日韩av一二三四区| 欧美一区二区三区综合| 在线视频日韩欧美| 国产精品一区二区羞羞答答| 日韩欧美一区三区| 久久亚洲国产成人精品无码区| 亚洲免费av网| 手机免费av片| 日韩无套无码精品| aa在线观看视频| 国产91在线亚洲| 一本二本三本亚洲码| 伊人成人免费视频| 伊人色在线视频| 一女二男3p波多野结衣| 日本爱爱免费视频| 欧美日韩大尺度| 乱子伦视频在线看| 日韩欧美在线播放视频| 国产无限制自拍| 精品久久久无码人妻字幂| 亚洲一区 在线播放| 最近中文字幕免费mv| 懂色av一区二区三区四区五区| www.com污| 午夜不卡福利视频| 三年中文在线观看免费大全中国| 国内外成人免费在线视频| 在线观看亚洲色图| www.com黄色片| 色啦啦av综合| 日本中文字幕在线不卡| 亚洲最新免费视频| 天天做天天爱天天高潮| 特级西西444| 蜜桃网站在线观看| 久青草视频在线播放| 水蜜桃色314在线观看| 久久久亚洲精品无码| 欧美色图另类小说| 99色精品视频| 久久综合伊人77777麻豆最新章节| 成人免费在线观看视频网站| www.色就是色.com| 特黄特黄一级片| 成人免费a级片| 欧美久久久久久久久久久久久| 黄色一级在线视频| www.日日操| 亚洲精品20p| 日本高清视频免费在线观看| 精品成在人线av无码免费看| 久久成人免费观看| 天天天干夜夜夜操| 中文字幕剧情在线观看| 久久亚洲国产成人精品无码区| 欧美,日韩,国产在线| 男人的天堂日韩| 午夜啪啪免费视频| 久久久久久www| 成人精品视频一区二区| 午夜福利123| 久久这里只有精品23| 黄色一级大片在线观看| 五月六月丁香婷婷| 日本十八禁视频无遮挡| 国内自拍视频网| 97超碰在线视| 欧美一级黄色影院| 亚洲综合123| 国产96在线 | 亚洲| 欧美伦理片在线观看| 国产激情片在线观看| 欧美国产亚洲一区|